Logo image of HBC.OL

HOFSETH BIOCARE ASA (HBC.OL) Stock Overview

Europe - OSL:HBC - NO0010598683 - Common Stock

1.93 NOK
+0.08 (+4.61%)
Last: 10/30/2025, 9:46:14 AM

HBC.OL Key Statistics, Chart & Performance

Key Statistics
Market Cap762.50M
Revenue(TTM)262.17M
Net Income(TTM)-137022000
Shares395.08M
Float204.28M
52 Week High3.6
52 Week Low1.16
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.33
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2011-12-02
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


HBC.OL short term performance overview.The bars show the price performance of HBC.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5

HBC.OL long term performance overview.The bars show the price performance of HBC.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40

The current stock price of HBC.OL is 1.93 NOK. In the past month the price increased by 7.27%. In the past year, price increased by 17.52%.

HOFSETH BIOCARE ASA / HBC Daily stock chart

HBC.OL Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 21.36 343.42B
AMG.DE AMGEN INC 13.46 135.80B
1GILD.MI GILEAD SCIENCES INC 15.92 131.38B
GIS.DE GILEAD SCIENCES INC 15.22 125.62B
VX1.DE VERTEX PHARMACEUTICALS INC 24.89 92.93B
1AE.DE ARGENX SE 96.58 44.18B
ARGX.BR ARGENX SE 99.68 45.60B
22UA.DE BIONTECH SE-ADR N/A 21.50B
IDP.DE BIOGEN INC 9.32 18.80B
1MRNA.MI MODERNA INC N/A 8.99B
0QF.DE MODERNA INC N/A 8.39B
1EXEL.MI EXELIXIS INC 17.15 8.26B

About HBC.OL

Company Profile

HBC logo image Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. The company is headquartered in Alesund, More Og Romsdal. The company went IPO on 2011-12-02. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

Company Info

HOFSETH BIOCARE ASA

Kipervikgata 13

Alesund MORE OG ROMSDAL NO

Employees: 75

HBC Company Website

HBC Investor Relations

Phone: 4773102200

HOFSETH BIOCARE ASA / HBC.OL FAQ

Can you describe the business of HOFSETH BIOCARE ASA?

Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. The company is headquartered in Alesund, More Og Romsdal. The company went IPO on 2011-12-02. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.


What is the stock price of HOFSETH BIOCARE ASA today?

The current stock price of HBC.OL is 1.93 NOK. The price increased by 4.61% in the last trading session.


Does HOFSETH BIOCARE ASA pay dividends?

HBC.OL does not pay a dividend.


What is the ChartMill rating of HOFSETH BIOCARE ASA stock?

HBC.OL has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Should I buy HBC stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on HBC.OL.


Can you provide the market cap for HOFSETH BIOCARE ASA?

HOFSETH BIOCARE ASA (HBC.OL) has a market capitalization of 762.50M NOK. This makes HBC.OL a Small Cap stock.


HBC.OL Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to HBC.OL. When comparing the yearly performance of all stocks, HBC.OL turns out to be only a medium performer in the overall market: it outperformed 54.76% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

HBC.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to HBC.OL. HBC.OL may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HBC.OL Financial Highlights

Over the last trailing twelve months HBC.OL reported a non-GAAP Earnings per Share(EPS) of -0.33. The EPS decreased by -9.45% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -35.39%
ROE -13486.42%
Debt/Equity 203.13
Chartmill High Growth Momentum
EPS Q2Q%-43.56%
Sales Q2Q%-5.2%
EPS 1Y (TTM)-9.45%
Revenue 1Y (TTM)18.16%

HBC.OL Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

HBC.OL Ownership

Ownership
Inst Owners34.27%
Ins Owners0.64%
Short Float %N/A
Short RatioN/A